Daniel Moreira, MD, MEd

Assistant Member, St. Jude Faculty

Director, Global Professional Education
Co-Director, Global Neuro-Oncology Program

Departments

Education

MD – Tecnológico de Monterrey, Monterrey, Mexico
Internship and Residency – Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
Pediatric Hematology/Oncology Fellowship – Children’s Hospital Colorado, Aurora, Colorado
Global Health Fellowship - St. Jude Children’s Research Hospital, Memphis, Tennessee
Pediatric Neuro-Oncology Fellowship - St. Jude Children’s Research Hospital, Memphis, Tennessee
MEd - Johns Hopkins University, Baltimore, Maryland

Honors & Awards

2013 HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award, American Society of Hematology
2014 Blackfan Research Award, Cincinnati Children’s Hospital Medical Center
2021 ASCO Global Young Investigator Award

Research Interests

Global pediatric oncology
- improving the outcome of children with cancer in low-and middle-income countries through evidence-based education and workforce optimization
Pediatric neuro-oncology
- improving the survival and reducing the morbidity of children with central nervous system tumors across the world through resource-level adjusted approaches

Moreira Clinical Research Profile

Contact Information

Daniel Moreira, MD, MEd Global Pediatric Medicine MS 721, Room S2008 St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678

Email: daniel.moreira@stjude.org
Phone: (901) 595-1911
Fax: (901) 595-5319

St. Jude Faculty List

Selected Publications

Sniderman ER, Graetz DE, Agulnik A, Radhikesh R, Vedaraju Y, Chen Y, Devidas M, Chantada G, Hessissen L, Dalvi R, Pritchard-Jones K, Rodriguez Galindo C, Moreira DC. Impact of the COVID-19 Pandemic on Pediatric Oncology Providers Globally: A Mixed- Methods Study. Cancer Apr 1;128(7):1493-1502, 2022.

Chiang J, Moreira DC, Pytel N, Liu Y, Blackburn P, Shi Z, Cardenas M, Wheeler DA, Furtado LV. CTNNB1-altered medulloblastoma shows the immunophenotypic, DNA methylation, and transcriptomic profiles of SHH-activated, and not WNT-activated, medulloblastoma. Neuropathol Appl Neurobiol Mar 23;e12815, 2022.

Upadhyaya SA, Campagne O, Billups CA, Orr BA, Onar-Thomas A, Tatevossian RG, Mostafavi R, Myers JR, Vinitsky A, Moreira DC, Lindsay HB, Kilburn L, Baxter P, Smith A, Crawford JR, Partap S, Bendel AE, Aguilera DG, Nichols KE, Rampersaud E, Ellison DW, Klimo P, Patay Z, Robinson GW, Broniscer A, Stewart CF, Wetmore C, Gajjar A. Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor. Neuro Oncol Jun 2, 2022.

Graetz DE, Sniderman E, Villegas CA, Kaye EC, Ragab I, Laptsevich A, Maliti B, Naidu G, Huang H, Gassant PY, Nunes Silva L, Arce D, Montoya Vasquez J, Arora RS, Alcasabas AP, Rusmawatiningtyas D, Raza MR, Velasco P, Kambugu J, Vinitsky A, Rodriguez-Galindo C, Agulnik A, Moreira DC and the COVIMPACT study Group. Resilience in Global Pediatric Oncology Care Delivery During the COVID-19 Pandemic. Cancer Feb 15;128(4):797-807, 2022.

Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y, Chantada G, Metzger ML, Mukkada S, Force LM, Friedrich P, Lam C, Sniderman E, Bhakta N, Hessissen L, Dalvi R, Devidas M Pritchard-Jones K, Rodriguez-Galindo C, Moreira DC. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health May;5(5):332-340, 2021.

Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, Homsi MR, Muniz-Talavera H, Ranadive R, Metzger M, Friedrich P, Agulnik A, Jeha S, Lam C, Dalvi R, Hessissen L, Moreira DC, Santana VM, Sullivan M, Bouffet E, Caniza MA, Devidas M, Pritchard-Jones K, Rodriguez-Galindo C, on behalf of the Global Registry of COVID-19 in Childhood Cancer. Global Characteristics and Outcomes of SARS-CoV-2 Infection Among Children and Adolescents with Cancer: A Report from the Global Registry of COVID-19 in Childhood Cancer Cohort Study. Lancet Oncol Oct;22(10):1416-1426, 2021.

Moreira DC, Sniderman E, Mukkada S, Chantada G, Bhakta N, Foster W, Avula M, Homsi MR, Faughan L, Happ B, Andujar A, Sonnenfelt J, Dalvi R, Frazier AL, Hessissen L, Kearns PR, Luna-Fineman S, Moreno A, Khan MS, Sullivan M, Devidas M, Santana V, Caniza M, Pritchard-Jones K, Rodriguez-Galindo C. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A Response for the Pediatric Oncology Community by SIOP and St. Jude Global. Pediatr Blood Cancer May;68(5):e28962, 2021.

Moreira DC, Gajjar A, Patay Z, Boop F, Chiang F, Merchant TE, Santiago T, Schaeffer E, Sonnenfelt J, Andujar A, Shuler A, Rodriguez-Galindo C, Qaddoumi I. Creation of a Successful Multidisciplinary Course in Pediatric Neuro-Oncology with a Systematic Approach to Curriculum Development. Cancer Apr 1;127(7):1126-1133, 2021.

Moreira DC, Millen GC, Sands S, Kearns PR, Hawkins DS. The Care of Children with Cancer During the COVID-19 Pandemic. Am Soc Clin Oncol Educ Book Mar;41:1-10, 2021.

Moreira DC, Venkataraman S, Subramanian A, Desisto J, Balakrishnan I, Prince E, Pierce A, Greisinger A, Green A; Eberhardt CG, Foreman NK, Vibhakar R. Targeting MYC-Driven Replication Stress in Medulloblastoma with AZD1775 and Gemcitabine. J Neurooncol May;147(3):531-545, 2020.

Chiang J, Harreld JH, Tinkle CL, Moreira DC, Li X, Acharya S, Qaddoumi I, Ellison DW. A single-center study of the clinicopathologic correlates of 55 gliomas with a MYB or MYBL1 alteration. Acta Neuropathol Dec;138(6):1091-1092, 2019.

Witt DA, Donson AM, Amani V, Moreira DC, Sanford B, Hoffman LM, Handler MH, Mulcahy Levy JM, Jones KL, Nellan A, Foreman NK, Griesinger AM. Specific Expression of PD-L1 in RELA-Fusion Supratentorial Ependymoma: Implications for PD-1 Targeted Therapy. Pediatr Blood Cancer May;65(5):e26960, 2018.

Griesinger AM, Witt DA, Grob ST, Georgio Westover SR, Donson AM, Mulcahy Levy JM, Wong R, Moreira DC, BalakrishnanI, HandlerMH, Vibhakar R, Venkataraman S, Foreman NK. Epigenetic silencing of LDOC1 leads to NF-kB hyperactivation in posterior fossa group A ependymoma. Neuro Oncol Oct 1;19(10):1350-1360, 2017.

Mizukawa B, O'Brien E, Moreira DC, Wunderlich M, Duan X, Liu W, Orr E, Grimes HL, Zheng Y, Mulloy J. Cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation. Blood Sep 14;130(11):1336-1346, 2017.

Moreira DC, Ng CJ, Quinones R, Liang X, ChungDW, Di Paola J. Microangiopathic Hemolytic Anemia Due to ADAMTS13 Loss in Idiopathic Systemic Capillary Leak Syndrome. J Thromb Haemost Dec;14(12):2353-2355, 2016.

Last update: July 2022